Nature, Vol.581, No.7808, 247-248, 2020
Dozens of coronavirus drugs are in development - what happens next?
How to make enough coronavirus drugs in a hurry Drug manufacturers face supply-chain weaknesses and sourcing issues as they ramp up complex production processes to meet global demand. Drug manufacturers face supply-chain weaknesses and sourcing issues as they ramp up complex production processes to meet global demand.